Literature DB >> 16034072

Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity.

Marco Rossi1, James W Young.   

Abstract

Dendritic cells (DCs) are specialized, bone marrow-derived leukocytes that are critical to the development of immunity. Investigators have emphasized the role of DCs in initiating adaptive or acquired MHC-restricted, Ag-specific T cell responses. More recent evidence supports important roles for DCs in the onset of innate immunity and peripheral tolerance. Progress in the generation of DCs from defined hemopoietic precursors in vitro has revealed the heterogeneity of these APCs and their attendant divisions of labor. This review will address these developments in an attempt to integrate the activities of different DCs in coordinating innate and adaptive immunity.

Entities:  

Mesh:

Year:  2005        PMID: 16034072     DOI: 10.4049/jimmunol.175.3.1373

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  92 in total

1.  Stress-induced redistribution of immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter Award winner.

Authors:  Firdaus S Dhabhar; William B Malarkey; Eric Neri; Bruce S McEwen
Journal:  Psychoneuroendocrinology       Date:  2012-06-22       Impact factor: 4.905

Review 2.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

3.  Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.

Authors:  Andrés A Herrada; Francisco J Contreras; Jaime A Tobar; Rodrigo Pacheco; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

4.  Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak/STAT transcription factors from patients with rheumatoid arthritis.

Authors:  J G Walker; M J Ahern; M Coleman; H Weedon; V Papangelis; D Beroukas; P J Roberts-Thomson; M D Smith
Journal:  Ann Rheum Dis       Date:  2007-01-12       Impact factor: 19.103

5.  Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.

Authors:  C Cubillos-Zapata; E Guzman; A Turner; S C Gilbert; H Prentice; J C Hope; B Charleston
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

6.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

7.  Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.

Authors:  Liyan Lin; Juanbing Wei; Yuqing Chen; Aimin Huang; Kay Ka-Wai Li; Wenmin Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2013-12-10       Impact factor: 4.553

8.  Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.

Authors:  Rebekah K O'Donnell; Rosemarie Mick; Michael Feldman; Satoshi Hino; Yan Wang; Marcia S Brose; Ruth J Muschel
Journal:  Cancer Lett       Date:  2007-06-18       Impact factor: 8.679

9.  Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis.

Authors:  Matthew N Meriggioli; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.

Authors:  Nadja Thönes; Anna Herreiner; Lysann Schädlich; Konrad Piuko; Martin Müller
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.